The past week in Delaware’s Chancery Court saw an eclectic mix of issues on the docket, from identity-based voting provisions to algorithms designed to reject claims. One highlight was a complaint lodged by Tesla CEO, Elon Musk, over what he deemed “egregious” legal fees. Interestingly, the court also found itself presiding over a case featuring, of all things, splattered waffles.
However, more weighty matters also featured on the court’s agenda. Shareholders of Fox Corp. continued to launch derivative suits, reflecting the growing trend of shareholders seeking legal recourse. In another significant development, the court reached an $84 million settlement conclusion in the case challenging the 2018 sale of the biotech venture Bioverativ Inc. to Sanofi Inc.
These recent developments represent just a snapshot of the dynamic nature of Delaware’s court of equity, underscoring its position as a central hub for high-profile commercial litigation cases. For a comprehensive view of these legal happenings, a detailed account of the week’s rulings can be found at Law360.